Nu Skin (NUS) Form 4: Director Sale of 6,489 Shares Reported

Rhea-AI Filing Summary

Laura Nathanson, a director of Nu Skin Enterprises (NUS), reported a sale of 6,489 shares of Class A common stock on 09/04/2025 at a price of $12.22 per share. After the transaction she beneficially owns 33,149 shares, reported as directly held. The Form 4 was signed by an attorney-in-fact on her behalf.

Positive

• Transaction fully disclosed on Form 4 with date, price, and post-transaction holdings
• Reporting person remains a holder with 33,149 shares after the sale

Negative

• Director reduced direct holdings by 6,489 shares through the reported sale

Insights

Financial Analyst

TL;DR: Director sale of a modest number of shares; holding remains meaningful but transaction appears routine.

The reported sale of 6,489 shares at $12.22 reduces the director's direct stake to 33,149 shares. For a public company insider, this size of sale is typically non-material to ownership percentage and often reflects diversification or personal liquidity needs rather than a change in view on company fundamentals. No derivatives or other transactions were reported.

Corporate Governance Expert

TL;DR: Disclosure complies with Section 16 reporting; transaction shows ongoing transparency but no governance red flag.

The Form 4 properly identifies the reporting person as a director and discloses the sale date, amount, and price, with a signature by attorney-in-fact. There are no indications of related-party transfers, 10b5-1 plan boxes checked, or coordinated filings. This appears to be a routine insider sale with full disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nathanson Laura

(Last) (First) (Middle)

C/O NU SKIN ENTERPRISES, INC.

75 W CENTER STREET

(Street)

PROVO UT 84601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NU SKIN ENTERPRISES, INC. [ NUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/04/2025		S		6,489	D	$12.22	33,149	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gregory Belliston as Attorney-in-Fact for Laura Nathanson	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Laura Nathanson report in the Form 4 for NUS?

The Form 4 reports a sale of 6,489 Class A shares on 09/04/2025 at $12.22 per share and a post-transaction holding of 33,149 shares.

Is the reporting person a director or officer of Nu Skin (NUS)?

Yes; the filing indicates the reporting person, Laura Nathanson, is a director of Nu Skin Enterprises.

Were any derivative transactions reported for NUS in this Form 4?

No; Table II for derivative securities contains no reported transactions in this filing.

Was the Form 4 signed and who signed it?

The Form 4 was signed on 09/04/2025 by Gregory Belliston as Attorney-in-Fact for Laura Nathanson.

Does the filing indicate a 10b5-1 trading plan or special instruction?

The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan (no plan box is checked in the provided content).